SCHEMBL8276134

SCHEMBL8276134

Nc1cc(F)ccc1N1CCC(CNC(=O)[C@H](O)[C@@H](O)c2ccccn2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADAM17 P78536 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ NPY2R P49146 3/20 0.37
▸ RPS6KB1 P23443 2/20 0.36
▸ CKS1B P61024 1/20 0.36
▸ SKP1 P63208 1/20 0.36
▸ SKP2 Q13309 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ GAA P10253 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ F2 P00734 1/20 0.36
▸ PRSS1 P07477 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ ADORA2A P29274 1/20 0.35
▸ SCD O00767 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8273641 0.89 RPS6KB1 (0.39) ADAM17KMT2ARPS6KB1CKS1BSKP1
SCHEMBL8215266 0.88 CHRM4 (0.47) ADAM17RPS6KB1SCN5ASCN9A
SCHEMBL8273636 0.81 ALDH1A1 (0.39) ADAM17RPS6KB1CKS1BSKP1SKP2
SCHEMBL8273633 0.80 CKS1B (0.41) RPS6KB1CKS1BSKP1SKP2ALDH1A1
SCHEMBL8273638 0.80 ALDH1A1 (0.38) ADAM17RPS6KB1CKS1BSKP1SKP2
SCHEMBL8275481 0.80 PIK3CB (0.43) CKS1BSKP1SKP2ALDH1A1GAA
SCHEMBL8273640 0.79 ALDH1A1 (0.38) ADAM17RPS6KB1CKS1BSKP1SKP2
SCHEMBL8276118 0.79 ADAM17 (0.43) ADAM17MEN1KMT2AALDH1A1GAA
SCHEMBL8274407 0.79 ADAM17 (0.43) ADAM17MEN1KMT2AALDH1A1GAA
SCHEMBL8275981 0.79 NAMPT (0.42) ADAM17RPS6KB1ALDH1A1L3MBTL1F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005121130-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2005-12-22 — — WO disclosed
Send feedback